185 related articles for article (PubMed ID: 26259553)
41. New mutations in two Dutch patients with early infantile galactosialidosis.
Groener J; Maaswinkel-Mooy P; Smit V; van der Hoeven M; Bakker J; Campos Y; d'Azzo A
Mol Genet Metab; 2003 Mar; 78(3):222-8. PubMed ID: 12649068
[TBL] [Abstract][Full Text] [Related]
42. Early-infantile galactosialidosis: clinical, biochemical, and molecular observations in a new patient.
Zammarchi E; Donati MA; Morrone A; Donzelli GP; Zhou XY; d'Azzo A
Am J Med Genet; 1996 Aug; 64(3):453-8. PubMed ID: 8862621
[TBL] [Abstract][Full Text] [Related]
43. Lysosomal high molecular weight multienzyme complex.
Ostrowska H; Krukowska K; Kalinowska J; Orłowska M; Lengiewicz I
Cell Mol Biol Lett; 2003; 8(1):19-24. PubMed ID: 12655352
[TBL] [Abstract][Full Text] [Related]
44. Candidate molecules for chemical chaperone therapy of GM1-gangliosidosis.
Higaki K; Ninomiya H; Suzuki Y; Nanba E
Future Med Chem; 2013 Sep; 5(13):1551-8. PubMed ID: 24024947
[TBL] [Abstract][Full Text] [Related]
45. A new heterozygous compound mutation in the
Nakajima H; Ueno M; Adachi K; Nanba E; Narita A; Tsukimoto J; Itoh K; Kawakami A
Hum Genome Var; 2019; 6():22. PubMed ID: 31044084
[TBL] [Abstract][Full Text] [Related]
46. Development and medical application of unsaturated carbaglycosylamine glycosidase inhibitors.
Ogawa S; Kanto M; Suzuki Y
Mini Rev Med Chem; 2007 Jul; 7(7):679-91. PubMed ID: 17627580
[TBL] [Abstract][Full Text] [Related]
47. Intracellular processing and maturation of mutant gene products in hereditary beta-galactosidase deficiency (beta-galactosidosis).
Oshima A; Yoshida K; Itoh K; Kase R; Sakuraba H; Suzuki Y
Hum Genet; 1994 Feb; 93(2):109-14. PubMed ID: 8112731
[TBL] [Abstract][Full Text] [Related]
48. A case of galactosialidosis.
Nobeyama Y; Honda M; Niimura M
Br J Dermatol; 2003 Aug; 149(2):405-9. PubMed ID: 12932252
[TBL] [Abstract][Full Text] [Related]
49. Processing of lysosomal beta-galactosidase. The C-terminal precursor fragment is an essential domain of the mature enzyme.
van der Spoel A; Bonten E; d'Azzo A
J Biol Chem; 2000 Apr; 275(14):10035-40. PubMed ID: 10744681
[TBL] [Abstract][Full Text] [Related]
50. Intracerebroventricular enzyme replacement therapy with β-galactosidase reverses brain pathologies due to GM1 gangliosidosis in mice.
Chen JC; Luu AR; Wise N; Angelis R; Agrawal V; Mangini L; Vincelette J; Handyside B; Sterling H; Lo MJ; Wong H; Galicia N; Pacheco G; Van Vleet J; Giaramita A; Fong S; Roy SM; Hague C; Lawrence R; Bullens S; Christianson TM; d'Azzo A; Crawford BE; Bunting S; LeBowitz JH; Yogalingam G
J Biol Chem; 2020 Sep; 295(39):13532-13555. PubMed ID: 31481471
[TBL] [Abstract][Full Text] [Related]
51. Primary and secondary elastin-binding protein defect leads to impaired elastogenesis in fibroblasts from GM1-gangliosidosis patients.
Caciotti A; Donati MA; Bardelli T; d'Azzo A; Massai G; Luciani L; Zammarchi E; Morrone A
Am J Pathol; 2005 Dec; 167(6):1689-98. PubMed ID: 16314480
[TBL] [Abstract][Full Text] [Related]
52. Molecular pathology of galactosialidosis in a patient affected with two new frameshift mutations in the cathepsin A/protective protein gene.
Richard C; Tranchemontagne J; Elsliger MA; Mitchell GA; Potier M; Pshezhetsky AV
Hum Mutat; 1998; 11(6):461-9. PubMed ID: 9603439
[TBL] [Abstract][Full Text] [Related]
53. Early-infantile galactosialidosis: prenatal presentation and postnatal follow-up.
Patel MS; Callahan JW; Zhang S; Chan AK; Unger S; Levin AV; Skomorowski MA; Feigenbaum AS; O'Brien K; Hellmann J; Ryan G; Velsher L; Chitayat D
Am J Med Genet; 1999 Jul; 85(1):38-47. PubMed ID: 10377011
[TBL] [Abstract][Full Text] [Related]
54. [Orientation of three lysosomal enzymes in the mouse inner ear and hearing loss in enzyme gene deficiency].
Guo YK; Xie DH; Yang XM
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2006 Feb; 31(1):79-84. PubMed ID: 16562682
[TBL] [Abstract][Full Text] [Related]
55. (5aR)-5a-C-Pentyl-4-epi-isofagomine: A powerful inhibitor of lysosomal β-galactosidase and a remarkable chaperone for mutations associated with GM1-gangliosidosis and Morquio disease type B.
Front S; Biela-Banaś A; Burda P; Ballhausen D; Higaki K; Caciotti A; Morrone A; Charollais-Thoenig J; Gallienne E; Demotz S; Martin OR
Eur J Med Chem; 2017 Jan; 126():160-170. PubMed ID: 27750150
[TBL] [Abstract][Full Text] [Related]
56. Tuning glycosidase inhibition through aglycone interactions: pharmacological chaperones for Fabry disease and GM1 gangliosidosis.
Aguilar-Moncayo M; Takai T; Higaki K; Mena-Barragán T; Hirano Y; Yura K; Li L; Yu Y; Ninomiya H; García-Moreno MI; Ishii S; Sakakibara Y; Ohno K; Nanba E; Ortiz Mellet C; García Fernández JM; Suzuki Y
Chem Commun (Camb); 2012 Jul; 48(52):6514-6. PubMed ID: 22618082
[TBL] [Abstract][Full Text] [Related]
57. Immunoelectron microscopical localization of lysosomal beta-galactosidase and its precursor forms in normal and mutant human fibroblasts.
Willemsen R; Hoogeveen AT; Sips HJ; van Dongen JM; Galjaard H
Eur J Cell Biol; 1986 Mar; 40(1):9-15. PubMed ID: 3084261
[TBL] [Abstract][Full Text] [Related]
58. [Genetic advances in galactosialidosis].
Hirasawa M
Nihon Rinsho; 1993 Sep; 51(9):2319-23. PubMed ID: 8411708
[TBL] [Abstract][Full Text] [Related]
59. Emphysema in an adult with galactosialidosis linked to a defect in primary elastic fiber assembly.
Lehman A; Mattman A; Sin D; Pare P; Zong Z; d'Azzo A; Campos Y; Sirrs S; Hinek A
Mol Genet Metab; 2012 May; 106(1):99-103. PubMed ID: 22386972
[TBL] [Abstract][Full Text] [Related]
60. Intrauterine growth retardation and placental vacuolization as presenting features in a case of GM1 gangliosidosis.
Brunetti-Pierri N; Mian A; Luetchke R; Graham BH
J Inherit Metab Dis; 2007 Oct; 30(5):823. PubMed ID: 17712606
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
